Gene therapy takes on deadly brain tumors in new trial
Disease control
Recruiting now
This study tests a gene therapy (HSV-tk) plus valacyclovir, along with radiation and chemotherapy, in people whose glioblastoma or high-grade astrocytoma has returned. The goal is to see if this combination can improve survival. About 62 participants will receive the treatment di…
Phase: PHASE1, PHASE2 • Sponsor: David Baskin MD • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC